0000950170-24-054726.txt : 20240507 0000950170-24-054726.hdr.sgml : 20240507 20240507170529 ACCESSION NUMBER: 0000950170-24-054726 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20240501 ITEM INFORMATION: Cost Associated with Exit or Disposal Activities ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240507 DATE AS OF CHANGE: 20240507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Akari Therapeutics Plc CENTRAL INDEX KEY: 0001541157 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981034922 STATE OF INCORPORATION: X0 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36288 FILM NUMBER: 24923075 BUSINESS ADDRESS: STREET 1: 22 BOSTON WHARF ROAD STREET 2: FL 7 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (646) 350-0702 MAIL ADDRESS: STREET 1: 22 BOSTON WHARF ROAD STREET 2: FL 7 CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Celsus Therapeutics Plc. DATE OF NAME CHANGE: 20130621 FORMER COMPANY: FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC DATE OF NAME CHANGE: 20120201 8-K 1 aktx-20240501.htm 8-K 8-K
0001541157truefalse00015411572024-05-012024-05-010001541157aktx:OrdinarySharesParValue0.0001PerShareMember2024-05-012024-05-010001541157dei:AdrMember2024-05-012024-05-01

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 1, 2024

 

Akari Therapeutics, Plc

(Exact Name of Registrant as Specified in Charter)

England and Wales

001-36288

98-1034922

(State or other jurisdiction
of incorporation)

(Commission File Number)

(I.R.S. Employer
Identification No.)

22 Boston Wharf Road FL 7

Boston, MA 02210

(Address, including zip code, of Principal Executive Offices)

Registrant’s telephone number, including area code: (929) 274-7510

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:

 

Trading Symbol(s)

 

Name of each

exchange on which registered

American Depository Shares, each representing 2,000 Ordinary Shares

 

AKTX

 

The Nasdaq Capital Market

Ordinary Shares, par value $0.0001 per share*

 

 

 

 

*Trading, but only in connection with the American Depositary Shares.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

Item 2.05 Costs Associated with Exit or Disposal Activities.

On May 1, 2024, Akari Therapeutics, Plc (the “Company”) began to implement a reduction-in-force of approximately 67% of its total workforce as a result of the recently announced program prioritization under which the Company's HSCT-TMA program was suspended. The reduction-in-force is part of an operational restructuring plan and includes the elimination of certain senior management positions. The purpose of the restructuring plan, including the reduction-in-force, is to reduce HSCT-TMA related operating costs, while supporting the execution of the Company’s long-term strategic plan.

The Company currently expects expenses related to the reduction-in-force, consisting primarily of cash severance and termination benefits and related costs, to be in the range of approximately $3.1 million to $3.2 million, which includes approximately $1.6 million of non-cash expenses related to vesting of equity awards. The Company expects these costs to be payable through the fourth quarter of 2024. These estimates are subject to a number of assumptions, and actual results may differ. The Company may also incur additional costs not currently contemplated due to events that may occur as a result of, or that are associated with, the operational restructuring plan, including the reduction-in-force.

 

Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

On May 7, 2024, Rachelle Jacques resigned from the Board of Directors (the “Board”), effective May 7, 2024. In connection with Ms. Jacques’ resignation from the Board, the Board reduced its size to five members. There was no disagreement between Ms. Jacques and the Company on any matter related to the Company’s operations, policies or practices that led to Ms. Jacques’ resignation from the Board.

Cautionary Note Regarding Forward-Looking Statements

This Current Report on Form 8-K contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements related to the expected costs and timing associated with reduction-in-force and expected reductions of operating expenses. These forward-looking statements are based on the Company’s current expectations and inherently involve significant risks and uncertainties. The Company’s actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to cost reduction efforts. In addition, the Company’s costs may be greater than anticipated and the workforce and operating expense reductions may have an adverse impact on the Company’s development activities. Additionally, these forward-looking statements should be considered in conjunction with the cautionary statements and risk factors described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, and its other filings filed from time to time with the Securities and Exchange Commission. The Company does not assume any obligation to update any forward-looking statement, except as required by law.

 

No Offer or Solicitation

 

This communication is not intended to and shall not constitute an offer to subscribe for, buy or sell or the solicitation of an offer to subscribe for, buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of, or offer to sell or buy, securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This communication is for informational purposes only. No offering of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended, and otherwise in accordance with applicable law.

 

Additional Information and Where to Find It

 

In connection with the proposed transaction, Akari and Peak Bio expect to file with the SEC a Registration Statement on Form S-4. The Registration Statement on Form S-4 will include a prospectus of Akari and a joint proxy statement of Akari and Peak Bio, and each party may also file other documents regarding the proposed transaction with the SEC. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ CAREFULLY

 

 

THE REGISTRATION STATEMENT ON FORM S-4, JOINT PROXY STATEMENT/ PROSPECTUS AND OTHER RELEVANT DOCUMENTS FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS THERETO AND ANY DOCUMENTS INCORPORATED BY REFERENCE THEREIN, IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION, RELATED MATTERS AND THE PARTIES TO THE PROPOSED TRANSACTION. You may obtain a free copy of the Registration Statement on Form S-4, joint proxy statement/prospectus and other relevant documents (if and when they become available) that are or will be filed with the SEC for free at the SEC’s website at www.sec.gov. Copies of the documents filed with the SEC by Akari will be available free of charge on Akari’s website at http://investor.akaritx.com/or by contacting Akari’s Investor Relations Department at http://investor.akaritx.com/investor-resources/contact-us. Copies of the documents filed with the SEC by Peak Bio will be available free of charge on Peak Bio’s website at https://peak-bio.com/investorsor by contacting Peak Bio’s Investor Relations Department at https://peak-bio.com/contact.

 

Participants in the Solicitation

 

Akari, Peak Bio and their respective directors and executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. Information about the directors and executive officers of Akari, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in Akari’s Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on March 29, 2024, subsequent quarterly and current reports on Form 10-Q and -K, respectively, and other documents that may be filed from time to time with the SEC. Information about the directors and executive officers of Peak Bio, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in Peak Bio’s proxy statement for its 2022 Special Meeting of Stockholders, which was filed with the SEC on October 19, 2022, the Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on June 29, 2023, subsequent quarterly and current reports on Form 10-Q and Form 8-K, respectively, and other documents that may be filed from time to time with the SEC. Other information regarding the participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the joint proxy statement/prospectus included in the Registration Statement on Form S-4 and other relevant materials to be filed with the SEC regarding the proposed transaction when such materials become available. Security holders, potential investors and other readers should read the joint proxy statement/prospectus, included in the Registration Statement on Form S-4 carefully when it becomes available before making any voting or investment decision. You may obtain free copies of these documents from Akari or Peak Bio using the sources indicated above.

 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Akari Therapeutics, Plc

Date: May 7, 2024

By:

/s/ Samir R. Patel, M.D.

Samir R. Patel, M.D.

Interim President and Chief Executive Officer

​

 

 EX-101.SCH 2 aktx-20240501.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Cover link:presentationLink link:calculationLink link:definitionLink Ordinary Shares, par value $0.0001 per share [Member] Ordinary Shares Par Value 0 . 0001 Per Share Member Document Transition Report Entity Public Float Security Reporting Obligation Pre-commencement Issuer Tender Offer No Trading Symbol Flag Entity Address, State or Province Trading Symbol Soliciting Material Entity Address, City or Town Written Communications Class of Stock [Domain] Document Shell Company Event Date Entity Central Index Key Document Registration Statement Entity Tax Identification Number Entity Registrant Name Entity Address, Address Line Three Class of Stock [Axis] Entity Current Reporting Status Current Fiscal Year End Date Elected Not To Use the Extended Transition Period Entity Primary SIC Number Entity Voluntary Filers Annual Information Form Document Period End Date Entity Address, Postal Zip Code Entity Interactive Data Current Entity Well-known Seasoned Issuer Entity Incorporation, State or Country Code Local Phone Number Document Annual Report Country Region Audited Annual Financial Statements City Area Code Extension Document Information [Line Items] Statement [Table] Document Fiscal Period Focus Other Reporting Standard Item Number Entity Common Stock, Shares Outstanding Entity Bankruptcy Proceedings, Reporting Current Pre-commencement Tender Offer Cover [Abstract] Document Fiscal Year Focus Document Accounting Standard Security Exchange Name Entity Emerging Growth Company Title of 12(g) Security Amendment Flag Document Shell Company Report Entity File Number Entity Address, Address Line Two Amendment Description Entity Small Business Entity Shell Company Entity Address, Address Line One Title of 12(b) Security Entity Address, Country Document Type Document Quarterly Report Entity Filer Category ADR [Member] Document Period Start Date Documents Incorporated by Reference [Text Block] XML 4 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover
May 01, 2024
Document Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 01, 2024
Entity File Number 001-36288
Entity Registrant Name Akari Therapeutics, Plc
Entity Central Index Key 0001541157
Entity Tax Identification Number 98-1034922
Entity Incorporation, State or Country Code X0
Entity Address, Address Line One 22 Boston Wharf Road FL 7
Entity Address, City or Town Boston
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02210
City Area Code 929
Local Phone Number 274-7510
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
ADR [Member]  
Document Information [Line Items]  
Title of 12(b) Security American Depository Shares, each representing 2,000 Ordinary Shares
Trading Symbol AKTX
Security Exchange Name NASDAQ
Ordinary Shares, par value $0.0001 per share [Member]  
Document Information [Line Items]  
Title of 12(b) Security Ordinary Shares, par value $0.0001 per share*
No Trading Symbol Flag true
EXCEL 5 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 6 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 7 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 3 23 1 false 2 0 false 0 false false R1.htm 100000 - Document - Cover Sheet http://www.akaritx.com/20240501/taxonomy/role/Cover Cover Cover 1 false false All Reports Book All Reports aktx-20240501.htm aktx-20240501.xsd http://xbrl.sec.gov/dei/2023 false false JSON 11 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "aktx-20240501.htm": { "nsprefix": "aktx", "nsuri": "http://www.akaritx.com/20240501", "dts": { "inline": { "local": [ "aktx-20240501.htm" ] }, "schema": { "local": [ "aktx-20240501.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 1, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 65, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://www.akaritx.com/20240501/taxonomy/role/Cover", "longName": "100000 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_450494f8-c3de-4849-9f0c-9f8a9afe1cc9", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "aktx-20240501.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_450494f8-c3de-4849-9f0c-9f8a9afe1cc9", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "aktx-20240501.htm", "first": true, "unique": true } } }, "tag": { "dei_AdrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AdrMember", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "ADR [Member]", "documentation": "American Depositary Receipt (or American Depositary Share, ADS)." } } }, "auth_ref": [ "r10" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r15" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r15" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r12", "r14", "r15" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r16" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r20" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r17" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r15" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r18" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "aktx_OrdinarySharesParValue0.0001PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.akaritx.com/20240501", "localname": "OrdinarySharesParValue0.0001PerShareMember", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Ordinary Shares, par value $0.0001 per share [Member]", "documentation": "Ordinary Shares Par Value 0 . 0001 Per Share Member" } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r14" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r11" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.akaritx.com/20240501/taxonomy/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r19" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d-3" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r20": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 12 0000950170-24-054726-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-054726-xbrl.zip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aktx-20240501_htm.xml IDEA: XBRL DOCUMENT 0001541157 2024-05-01 2024-05-01 0001541157 aktx:OrdinarySharesParValue0.0001PerShareMember 2024-05-01 2024-05-01 0001541157 dei:AdrMember 2024-05-01 2024-05-01 0001541157 true false 8-K 2024-05-01 Akari Therapeutics, Plc X0 001-36288 98-1034922 22 Boston Wharf Road FL 7 Boston MA 02210 929 274-7510 false false false false American Depository Shares, each representing 2,000 Ordinary Shares AKTX NASDAQ Ordinary Shares, par value $0.0001 per share* false